Skip to main content
Clinical Trials/NL-OMON38691
NL-OMON38691
Not yet recruiting
Not Applicable

MR biopsy versus MR guided ultrasound fusion biopsy in prostate cancer diagnosis - MR biopsy versus MR guided US fusion biopsy in prostate cancer diagnosis

niversitair Medisch Centrum Sint Radboud0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • \- At least one negatieve systematic ultrasound guided biopsy
  • \- MR\-visible tumor \>10 mm diameter
  • \- PI\-RADS 4\-5

Exclusion Criteria

  • \- MR\-visible tumor \<10 mm diameter
  • \- PI\-RADS 1\-3
  • \- Patients with previous radiotherapy, hormonal therapy or local treatment of the prostate
  • \- Contra\-indication for MR imaging

Outcomes

Primary Outcomes

Not specified

Similar Trials